Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page
- Check6 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded site revision note v3.4.2 and removed prior notices about government funding lapse and NIH operating status (v3.4.1).SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a Results Posted date (2026-01-30) and associated results data for the TROPiCS-03 study across multiple cohorts. Updated the trial design to non-randomized, parallel assignment and expanded cohort descriptions (NSCLC subtypes, HNSCC, EC, ES-SCLC) with revised inclusion criteria and treatment regimens.SummaryDifference5%

- Check48 days agoChange DetectedUI updates include showing the glossary toggle and updating metadata, including Last Update Submitted that Met QC Criteria, Last Update Posted, the No FEAR Act capitalization change, and Revision: v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded 'Results Submitted' to the study's Results section, replacing the previous 'No Results Posted' status.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed. This change reflects a site version update without impacting the study details, eligibility, or user workflow.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.